Search Results for: drug patents

Program and Agenda, Roundtable on Prizes

Written by James Love
Wednesday, 07 January 2009

 Program and Agenda

(Draft 7Jan09)

Roundtable on De-linking R&D Incentives from Prices

Designing Innovation Inducement Prizes for Diagnostics, New Drugs and Vaccines for Type II and III diseases and conditions, with a particular focus on TB and Chagas Disease

 

Continue Reading →

Notes on the Bayh-Dole Act of 1980

Sep 2, 2009 The Bayh-Dole Act (or University and Small Business Patent Procedures Act) was originally enacted in 1980 as Public Law 96-517, and was amended in 1984 by Public Law 98-620. Among other things, the Bayh-Dole Act was designed… Continue Reading →

Abbott sought compulsory license in 2007 US patent dispute

Sunday, 29 April 2007

(When the shoe was on the other foot, Abbott asked for a compulsory license, while criticizing Thailand for issuing compulsory licenses)
 

On the 12th of January 2007, Abbott Laboratories lost a bid in a U.S. District Court (the Western District of Wisconsin) for a compulsory license on a patent held by Innogenetics, Inc. that a judge and jury said Abbott infringed to manufacture and sell Hepatitis C virus (HCV) genotyping test kits.

 

Continue Reading →

UNITAID Patent Pool for Medicines

In 2007 Medécins sans Frontières (MSF, Doctors Without Borders) and Knowledge Ecology International (KEI) presented a proposal for UNITAID to host a medicines patent pool.

In July 2008 the UNITAID Board supported the principle of establishing a patent pool for medicines to provide patients in low and middle income countries with increased access to more appropriate and lower price medicines.

Continue Reading →

Abbott (ABT): Select Joint Ventures, Partnerships, and Alliances

Monday, 10 September 2007

Select Joint Ventures, Partnerships, and Alliances with Big Pharma

Abbott and Millennium – In March 2001 Abbott and Millennium formed a strategic alliance for the discovery, development and commercialization of drugs and diagnostics in the area of obesity and diabetes.  This alliance also provided for non-exclusive technology transfer and the co-development of technology tools.  According to Millennium's 2001 SEC filing, the deal i Continue Reading →